Ronment for cancer development and metastasis. Br J Cancer 2013, 108:755?61. Bornstein P > 자유게시판

Ronment for cancer development and metastasis. Br J Cancer 2013, 108:755?61. Bornstein P, Sage EH: Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 2002, 14:608?16. Hanahan D, Coussens LM: Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309?22. Place AE, Jin Huh S, Polyak K: The microenvironment in breast cancer progression: biology and implications for treatment. Breast Cancer Res 2011, 13:227. Xouri G, Christian S: Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 2010, 21:40?6. Sharma P, Wagner K, Wolchok JD, Allison JP: Novel cancer immunotherapy agents with survival benefit: recent successes and next steps. Nat Rev Cancer 2011, 11:805?12. Angel TE, Aryal UK, Hengel SM, Baker ES, Kelly RT, Robinson EW, Smith RD: Mass spectrometry-based proteomics: existing capabilities and future directions. Chem Soc Rev 2012, 41:3912?928. Simona F, Laura S, Simona T, Riccardo A: Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives. Proteomics 2013, 13:1581?594. Mayne J, Starr AE, Ning Z, Chen R, Chiang CK, Figeys D: Fine tuning of proteomic technologies to PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/25751659 improve biological findings: advancements in 2011?013. Anal Chem 2014, 86:176?95. Zhang Q, Faca V, Hanash S: Mining the plasma proteome for disease applications across seven logs of protein abundance. J Proteome Res 2011, 10:46?0. Wolters DA, Washburn MP, Yates JR 3rd: An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 2001, 73:5683?690. Cardoza JD, Parikh JR, Ficarro SB, Marto JA: Mass spectrometry-based proteomics: qualitative identification to activity-based protein profiling. Wiley Interdiscip Rev Syst Biol Med 2012, 4:141?62. Uhlen M, Ponten F: Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 2005, 4:384?93. Chandra H, Reddy PJ, Srivastava S: Protein microarrays and novel detection platforms. Expert Rev Proteomics 2011, 8:61?9. Baird BN, Schliekelman MJ, Ahn YH, Chen Y, Roybal JD, Gill BJ, Mishra DK, Erez B, O'Reilly M, Yang Y, Patel M, Liu X, Thilaganathan N, Larina IV, Dickinson ME, West JL, Gibbons DL, Liu DD, Kim MP, Hicks JM, Wistuba II, Hanash SM, Kurie JM: Fibulin-2 is a driver of malignant progression in lung adenocarcinoma. PLoS One 2013, 8:e67054. Kim SH, Turnbull J, Guimond S: Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol 2011, 209:139?51. Ong SE, Kratchmarova I, Mann M: Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC). J Proteome Res 2003, 2:173?81. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, Zhang Q, Wong CH, Wang H, Ungewiss C, Ahn YH, Shin DH, Kurie JM, Hanash SM: Targets of the tumor suppressor miR-200 in regulation of the epithelialmesenchymal transition in cancer. Cancer Res 2011, 71:7670?682.25. Little GH, Noushmehr H, Baniwal SK, Berman BP, Coetzee GA, Frenkel B: Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Res Capecitabine 2012, 40:3538?547. 26. Rocco M, Malorni L, Cozzolino R, Palmieri G, Rozzo C, Manca A, Parente A, Chambery A: Proteomic profiling of human melanoma metastatic cell line secretomes. J Proteome Res 2011, 10:4703?714. 27. Mathias RA, Chen YS, Wang B, Ji H, Kapp EA, Moritz RL, Zhu.